FAQs
Frequently Asked Questions
Answers about Canna-Re’s research consulting services, project process, regulatory support, and how we can help advance your cannabis research.
Canna-Re provides research consulting at the intersection of public health, bioinformatics, clinical research, and evolving cannabis policy. We help organizations plan, coordinate, design, select, and strengthen scientifically rigorous cannabis research projects.
We support federal agencies, academic institutions, clinical study sites, study sponsors, contract research organizations, cannabis manufacturers, clinicians, pharmacists, and other organizations building evidence-based research programs.
Our services include:
-Research coordination and project management
-IRB submission guidance
-Grant writing, site feasibility, and budget development
-Epidemiological and bioinformatic study design
-Biostatistical planning and data collection
-Active study-site consulting
-Database, SOP, data collection, and regulatory-document development
-Clinical trial and FDA applications
Yes. Canna-Re can support the development and organization of IRB submission materials, including informed consent forms, study protocols, recruitment materials, and biological and/or environmental safety plans.
Final submission requirements and approval decisions remain with the applicable institutional review board.
Yes. We provide study-design consulting for investigator-initiated studies, chart reviews, prospective surveys, demographic data collection, population-level research, and other public health or bioinformatics projects.
Support may include methodology, platform selection, protocol development, sample selection, biostatistical analysis planning, data-collection strategies, study document formation, intervention design, and health education materials development.
Yes. Canna-Re provides ongoing consulting for active study sites. Services may include database design and management, standard operating procedure development, regulatory affairs and documentation, data analysis, technical assistance, results interpretation, and dissemination planning.
Canna-Re provides specialized documentation support for study sponsors, clinical research organizations, and clinical trial sites. This may include new drug application materials, medical device application materials, investigator brochures, and sponsor regulatory documents required for FDA submissions.
FDA acceptance, review, and approval decisions remain solely with the agency.
Canna-Re is a research consulting company. We provide coordination, study-design, documentation, metholodology, and regulatory support based on the needs of each project. We do not represent ourselves as the study sponsor, institutional review board, regulatory authority, or clinical trial site unless expressly stated in a project agreement.
No. Canna-Re provides research consulting services only. We do not manufacture, sell, prescribe, or distribute cannabis or cannabis products.
Canna-Re provides consulting services in alignment with applicable federal and state research requirements. Because cannabis laws, regulations, and agency guidance continue to evolve, each project is evaluated individually based on its location, scope, research activities, and participating organizations.
Yes. Canna-Re is based in Norristown, Pennsylvania, incorporated in Delaware, and serves clients nationally. Project availability may depend on the scope of work and any applicable federal, state, institutional, or study-specific requirements.
Consulting services are priced by project. Cost depends on the project’s scope, complexity, timeline, documentation requirements, and level of ongoing support. Canna-Re will review your needs before recommending pricing guidelines.
Canna-Re will review the information submitted through the consultation form and follow up to learn more about your organization, research needs, project stage, and timeline. If the project appears to be a good fit, the next step may include an introductory consultation and a customized scope of work.
Canna-Re typically responds within one to two business days. If your matter is time-sensitive, please indicate the deadline or level of urgency in your message.
Include a brief description of your organization, the type of research or study involved, the support you need, your current project stage, planned research methods, and any important deadlines. You do not need to have every detail finalized before reaching out.
Ready to advance your cannabis research?
Schedule a free discovery call — let’s map out the right approach together.
Canna-RE Enterprises LLC provides research consulting services only. We do not manufacture, sell, or distribute cannabis products. All consulting subject to applicable federal and state law.